Rahman M, Spitzhorn L, Wruck W, Hagenbeck C, Balan P, Graffmann N, et al. The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time. Stem Cell Res Ther. 2018;9:113 pubmed publisher

Charpentier M, Khedher A, Menoret S, Brion A, Lamribet K, Dardillac E, et al. CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair. Nat Commun. 2018;9:1133 pubmed publisher

Spitzhorn L, Rahman M, Schwindt L, Ho H, Wruck W, Bohndorf M, et al. Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections. Stem Cells Int. 2017;2017:5932706 pubmed publisher

Buonocore F, Kühnen P, Suntharalingham J, Del Valle I, Digweed M, Stachelscheid H, et al. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest. 2017;127:1700-1713 pubmed publisher

Aloia A, Petrova E, Tomiuk S, Bissels U, Déas O, Saini M, et al. The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features. Breast Cancer Res. 2015;17:146 pubmed publisher

Truong T, Huynh K, Nakatsu M, Deng S. SSEA4 is a potential negative marker for the enrichment of human corneal epithelial stem/progenitor cells. Invest Ophthalmol Vis Sci. 2011;52:6315-20 pubmed publisher

Gang E, Bosnakovski D, Figueiredo C, Visser J, Perlingeiro R. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007;109:1743-51 pubmed